FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2786371470> ?p ?o ?g. }

• W2786371470 endingPage "184" @default.
• W2786371470 startingPage "175" @default.
• W2786371470 abstract "To explore the metabolic phenotype of obesity-related secondary hypogonadism (SH) in men pre-replacement and post-replacement therapy with long-acting intramuscular (IM) testosterone undecanoate (TU).A prospective observational pilot study on metabolic effects of TU IM in male obesity-related SH (hypogonadal [HG] group, n = 13), including baseline comparisons with controls (eugonadal [EG] group, n = 15). Half the subjects (n = 7 in each group) had type 2 diabetes mellitus (T2D). Baseline metabolic assessment on Human Metabolism Research Unit: fasting blood samples; BodPod (body composition), and; whole-body indirect calorimetry. The HG group was treated with TU IM therapy for 6-29 months (mean 14.8-months [SD 8.7]), and assessment at the Human Metabolism Research Unit repeated. T-test comparisons were performed between baseline and follow-up data (HG group), and between baseline data (HG and EG groups). Data reported as mean (SD).Overall, TU IM therapy resulted in a statistically significant improvement in HbA1C (9 mmol/mol, P = 0.03), with 52% improvement in HOMA%B. Improvement in glycaemic control was driven by the HG subgroup with T2D, with 18 mmol/mol [P = 0.02] improvement in HbA1C. Following TU IM therapy, there was a statistically significant reduction in fat mass (3.5 Kg, P = 0.03) and increase in lean body mass (2.9 kg, P = 0.03). Lipid profiles and energy expenditure were unchanged following TU IM therapy. Comparisons between baseline data for HG and EG groups were equivalent apart from differences in testosterone, SHBG and basal metabolic rate (BMR).In men with obesity-related SH (including a subgroup with T2D), TU IM therapy improved glycaemic control, beta cell function, and body composition." @default.
• W2786371470 created "2018-02-23" @default.
• W2786371470 creator A5003486559 @default.
• W2786371470 creator A5004792687 @default.
• W2786371470 creator A5006243285 @default.
• W2786371470 creator A5012389412 @default.
• W2786371470 creator A5027919996 @default.
• W2786371470 creator A5030447992 @default.
• W2786371470 creator A5040684139 @default.
• W2786371470 creator A5050049384 @default.
• W2786371470 creator A5060053131 @default.
• W2786371470 creator A5060487067 @default.
• W2786371470 creator A5071079098 @default.
• W2786371470 date "2018-02-02" @default.
• W2786371470 modified "2023-09-24" @default.
• W2786371470 title "Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy" @default.
• W2786371470 cites W150516633 @default.
• W2786371470 cites W1917696566 @default.
• W2786371470 cites W1957255860 @default.
• W2786371470 cites W1965767786 @default.
• W2786371470 cites W1975704047 @default.
• W2786371470 cites W2017020170 @default.
• W2786371470 cites W2026457264 @default.
• W2786371470 cites W2033274053 @default.
• W2786371470 cites W2038996666 @default.
• W2786371470 cites W2041025069 @default.
• W2786371470 cites W2041811148 @default.
• W2786371470 cites W2077360526 @default.
• W2786371470 cites W2102179430 @default.
• W2786371470 cites W2107044995 @default.
• W2786371470 cites W2115459308 @default.
• W2786371470 cites W2124742293 @default.
• W2786371470 cites W2131274956 @default.
• W2786371470 cites W2136318734 @default.
• W2786371470 cites W2169467998 @default.
• W2786371470 cites W2193832301 @default.
• W2786371470 cites W2203168867 @default.
• W2786371470 cites W2208778639 @default.
• W2786371470 cites W2232805722 @default.
• W2786371470 cites W2343995045 @default.
• W2786371470 cites W2397743210 @default.
• W2786371470 cites W2495785123 @default.
• W2786371470 cites W2520423441 @default.
• W2786371470 cites W2586850193 @default.
• W2786371470 cites W2593659889 @default.
• W2786371470 doi "https://doi.org/10.1007/s12020-017-1516-x" @default.
• W2786371470 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5845623" @default.
• W2786371470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29396841" @default.
• W2786371470 hasPublicationYear "2018" @default.
• W2786371470 type Work @default.
• W2786371470 sameAs 2786371470 @default.
• W2786371470 citedByCount "15" @default.
• W2786371470 countsByYear W27863714702018 @default.
• W2786371470 countsByYear W27863714702019 @default.
• W2786371470 countsByYear W27863714702020 @default.
• W2786371470 countsByYear W27863714702021 @default.
• W2786371470 countsByYear W27863714702022 @default.
• W2786371470 crossrefType "journal-article" @default.
• W2786371470 hasAuthorship W2786371470A5003486559 @default.
• W2786371470 hasAuthorship W2786371470A5004792687 @default.
• W2786371470 hasAuthorship W2786371470A5006243285 @default.
• W2786371470 hasAuthorship W2786371470A5012389412 @default.
• W2786371470 hasAuthorship W2786371470A5027919996 @default.
• W2786371470 hasAuthorship W2786371470A5030447992 @default.
• W2786371470 hasAuthorship W2786371470A5040684139 @default.
• W2786371470 hasAuthorship W2786371470A5050049384 @default.
• W2786371470 hasAuthorship W2786371470A5060053131 @default.
• W2786371470 hasAuthorship W2786371470A5060487067 @default.
• W2786371470 hasAuthorship W2786371470A5071079098 @default.
• W2786371470 hasBestOaLocation W27863714701 @default.
• W2786371470 hasConcept C120863210 @default.
• W2786371470 hasConcept C126322002 @default.
• W2786371470 hasConcept C134018914 @default.
• W2786371470 hasConcept C147583825 @default.
• W2786371470 hasConcept C2777180221 @default.
• W2786371470 hasConcept C2777911890 @default.
• W2786371470 hasConcept C2779279991 @default.
• W2786371470 hasConcept C2780578515 @default.
• W2786371470 hasConcept C3019419337 @default.
• W2786371470 hasConcept C511355011 @default.
• W2786371470 hasConcept C555293320 @default.
• W2786371470 hasConcept C71315377 @default.
• W2786371470 hasConcept C71924100 @default.
• W2786371470 hasConcept C82736064 @default.
• W2786371470 hasConceptScore W2786371470C120863210 @default.
• W2786371470 hasConceptScore W2786371470C126322002 @default.
• W2786371470 hasConceptScore W2786371470C134018914 @default.
• W2786371470 hasConceptScore W2786371470C147583825 @default.
• W2786371470 hasConceptScore W2786371470C2777180221 @default.
• W2786371470 hasConceptScore W2786371470C2777911890 @default.
• W2786371470 hasConceptScore W2786371470C2779279991 @default.
• W2786371470 hasConceptScore W2786371470C2780578515 @default.
• W2786371470 hasConceptScore W2786371470C3019419337 @default.
• W2786371470 hasConceptScore W2786371470C511355011 @default.
• W2786371470 hasConceptScore W2786371470C555293320 @default.
• W2786371470 hasConceptScore W2786371470C71315377 @default.
• W2786371470 hasConceptScore W2786371470C71924100 @default.
• W2786371470 hasConceptScore W2786371470C82736064 @default.

• next